A comprehensive cancer center is examining breast cancer clinical trial participation among diverse patients. Reports indicate that low enrollment and racial disparities are limiting breast cancer treatment innovation, with various barriers preventing patients from participating in clinical trials. Efforts are being made to address these issues, including redefining communication of treatment options and broadening eligibility criteria to increase diversity among patients in cancer clinical trials.